Regeneron Pharmaceuticals, Inc. (RGO)
FSX
Real-time Data
06:00 AM
Day's Range
652.5052 wk Range
476.70Overview - RGO - Regeneron Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
55.99B
P/E (Trailing)
‪19.49‬
P/E (Forward)
‪15.67‬
PEG Ratio
‪-4.16‬
Price / Sales (TTM)
‪4.58‬
Price / Book
‪2.51‬
EV / EBITDA
‪13.57‬
Profitability
Gross Margin
‪86.56%‬
Profit Margin
‪27.86%‬
Operating Margin
‪33.10%‬
Return on Assets
‪6.52%‬
Return on Equity
‪14.04%‬
Ownership
Shares Outstanding
103.13M
Float
95.84M
Held by Insiders
‪2.08%‬
Held by Institutions
‪93.53%‬
Price stats
Beta
‪0.19‬
50-Day Avg
‪671.97‬
200-Day Avg
‪629.06‬
Dividends
Payout Ratio
‪9.01%‬
Frequency
Quarterly
Market Cap - RGO - Regeneron Pharmaceuticals, Inc.
Peers - RGO - Regeneron Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- RGOFSXRegeneron Pharmaceuticals, Inc.71.26BMarket Cap+31.09%52-week change19.49P/E (Trailing)‪27.86%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - RGO - Regeneron Pharmaceuticals, Inc.
About
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and metabolic disease, infectious disease, hematology, and rare disorders.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
